Institute of Molecular Biology Division of Natural Sciences |
N | Investment project title | Early diagnosis of overfatigue | |
1. | Sector | Medicine, sports medicine |
|
2. | Project description | The proposed product is а rapid and effective way for self assessment of Overtraining syndrome (OTS). OTS is usually caused in sportsmen and other persons exposed to heavy physical load if it is not compensated by enough resting/recovery. To date there is no effective way for fast diagnostics of OTS. We have developed an express test-system for OTS self-assessment, which is based on the measurement of saliva biomolecules. Other risk groups for OTS include persons exposed to excessive physical load, such as truck drivers, pilots, police and military officers, etc. The most common syndromes of OTS include loss of motivation, drop of performance, inability to concentrate, sleeping disturbances, depression, general aches, decreased immunity, increased susceptibility to infections and injuries. Our express test-system is an effective way for specific, fast and reliable self-diagnostics of the OTS. The potential market for our product is global and includes sports medicine, monitoring of physical load, the market of adaptogen biological active compounds and other areas requiring monitoring of physical load. |
|
3. | Project implementation period | 3 years | |
4. | Project location | Institute of Molecular Biology of NAS RA | |
5. | Project overall cost (USD) | 200.000 (design and manufacture of industrial prototype , small and medium-scale production, approvals and licenses) | |
6. | Required investments (USD) | 175.000 | |
7. | Own funds (USD) | 25.000 (has been already invested in R&D and preliminary trials) | |
8. | Creation of jobs | At the beginning of the project | At the end of the project |
5 - 10 | 30 - 40 | ||
9. | Payback period | 2-3 years | |
10. | Annual profitability index | 1.05 | |
11. | Detailed costs | - |
|
12. | Offer to investor | The organization of a joint venture, an investor’s share will depend on the amount of invested funds and project involvement stage |
|
13. | Contact details | Arsen Arakelyan, Director of the Institute of Molecular Biology of NAS RA |